FMIBlog2d
Global IVD Antibodies Market Expected to Reach USD 2 Billion by 2032, Driven by Increasing Prevalence of Chronic and Infectious Diseases | FMI
The USA remains the key contributor due to its advanced healthcare infrastructure, increasing investments in medical research, and the presence of major pharmaceutical and biopharmaceutical companies.
Scientists test accessible, affordable diagnostic tool for heart disease risk via molecular blood screening
A groundbreaking study has successfully translated high-field nuclear magnetic resonance (NMR) spectroscopy-based lipoprotein ...
Millions of people are spreading the world’s deadliest infectious disease unknowingly
Millions of people are spreading the world’s deadliest infectious disease unknowingly - World’s deadliest infectious disease ...
Business Insider11d
ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER
New Findings: Can Blood Markers Predict Who Benefits Most ... It is sponsored by the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID, which also ...